Bioson Pharmaceutical Applies for MFDS Approval of Non-Opioid Analgesic 'Opirangerin Hydrochloride'
Vivozon Pharmaceutical announced on the 22nd that it has applied for product approval from the Ministry of Food and Drug Safety for the non-narcotic analgesic 'Onapraju (Ophiranzerin Hydrochloride)'.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- [New York Stock Exchange] All Major Indices Close Lower as U.S. Treasury Yields Surge
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The indication is 'moderate to severe acute pain, including postoperative pain.' The contract manufacturing organization for the entire process is the US company Jubilant HollisterStier, LLC.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
